Episode 84: Clinical Conversations: NAFLD, The Sentinel Disease of Metabolic Syndrome

Episode 87: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 2 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org. In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. EPISODE GUESTS Dr. Shagun Bindlish, MD Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC RELATED RESOURCES Obesity Pillars [https://www.sciencedirect.com/journal/obesity-pillars]® [https://www.sciencedirect.com/journal/obesity-pillars]

Episode 86: Clinical Conversations: Therapies and Pharmacotherapy Treatment Options in Pediatrics

In this episode, we will be hearing from Dr. Suzanne Cuda, President and Medical Director for Alamo City Healthy Kids and Families. Joining her is Nancy Browne and Dr. Valarie O’Hara. Nancy is a nurse practitioner, pediatric obesity medicine specialist and is also a co-author of the OMA Pediatric Obesity Clinical Practice Statements. Dr. O’Hara is an ABOM certified obesity specialist and the medical director of the WOW 4 Wellness Clinic. Today’s topics are foundational therapies, shared decision making, off-label treatment and pharmacotherapy treatment options in pediatrics. EPISODE GUESTS Dr. Suzanne Cuda Nancy Browne Dr. Valarie O’Hara RELATED RESOURCES Pediatric Obesity Algorithm® [https://obesitymedicine.org/childhood-obesity/]OMA Pediatric Resources Webpage [https://obesitymedicine.org/clinician-resources/pediatric-obesity-resources/\]OMA Blog [https://obesitymedicine.org/category/blog/]

Episode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org. In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. EPISODE GUESTS Dr. Shagun Bindlish, MD Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC RELATED RESOURCES Obesity Pillars [https://www.sciencedirect.com/journal/obesity-pillars]® [https://www.sciencedirect.com/journal/obesity-pillars]

Episode 84: Clinical Conversations: NAFLD, The Sentinel Disease of Metabolic Syndrome

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Robert Lustig, discuss non-alcoholic fatty liver disease and obesity. Dr. Lustig is a professor of pediatric in the division of endocrinology at UCSF. In addition to his rich contribution to the medical literature, he is an author of several best-selling books, and a passionate advocate for promoting metabolic health and nutrition especially with respect to the health risks of sugar. He was the keynote speaker at the OMA’s 2022 Fall Obesity Summit. His presentation was titled ” The BIG Picture: NAFLD, the sentinel disease of metabolic syndrome”. Topics discussed include the health consequences of sugar consumption, the prevalence of NAFLD, diagnosing NAFLD, and treatment through medication, nutrition, and weight loss. EPISODE GUESTS Dr. Nick Pennings, DO, FOMA Dr. Robert Lustig, MD RESOURCES MENTIONED Fat Chance and Metabolical, by Dr. Lustig [https://robertlustig.com/books/] RELATED RESOURCES Overcoming Obesity Conference [https://obesitymedicine.org/fall/]Obesity Algorithm® [https://obesitymedicine.org/obesity-algorithm/]Obesity Medicine Association Blog [https://obesitymedicine.org/category/blog/]

Episode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars [https://obesitymedicine.org/obesity-pillars/], for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars [https://www.journals.elsevier.com/obesity-pillars]. We then discuss this new science with obesity experts. In this three part series, Dr. Bays and Dr. Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. EPISODE GUESTS Tiffany Lowe-Clayton, DO Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC RELATED RESOURCES Obesity PillarsJournal [https://obesitymedicine.org/obesity-pillars/]